English
2-Hydroxy-5-Methylpyridine CAS 1003-68-5 Purity ≥99.0% Pirfenidone Intermediate Hoobkas Featured duab
  • 2-Hydroxy-5-Methylpyridine CAS 1003-68-5 Purity ≥99.0% Pirfenidone Intermediate Factory

2-Hydroxy-5-Methylpyridine CAS 1003-68-5 Purity ≥99.0% Pirfenidone Intermediate Factory

Lus piav qhia luv luv:

Lub npe tshuaj: 2-Hydroxy-5-Methylpyridine

Synonyms: 5-Methyl-2(1H)-Pyridinone

CAS: 1003-68-5 Nr

Purity: ≥99.0%

Cov tsos mob: Tawm-dawb mus rau daj crystalline hmoov

Intermediate of Pirfenidone (CAS: 53179-13-8) los kho Idiopathic Pulmonary Fibrosis (IPF)

E-Mail: alvin@ruifuchem.com


Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chaw tsim khoom, siab purity, coj mus muag ntau lawm
Lub npe tshuaj: 2-Hydroxy-5-Methylpyridine
CAS: 1003-68-5 Nr

Chemical Properties:

Tshuaj npe 2-Hydroxy-5-Methylpyridine
Synonyms 5-Methyl-2(1H)-Pyridinone;2-Hydroxy-5-Picoline;6-Hydroxy-3-Picoline;5-Methyl-2-Pyridinol
CAS Nr 1003-68-5
CAT Number Qauv TSIS MUAJ: RF-PI549
Tshuag xwm txheej Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula C6H7 Nr
Molecular Luj 109.13 Nws
Melting Point 183.0 ~ 187.0 ℃ (lit.)
Solubility Soluble hauv Methanol
Hom Ruifu Tshuaj

Specifications:

Yam khoom Specifications
Qhov tshwm sim Off-White to Yellow Crystalline Powder
Purity ≥99.0%
Moisture Content (KF) ≤0.50%
Residue ntawm Ignition ≤0.50%
Ib qho Impurity ≤0.50%
Tag nrho cov impurities ≤ 1.00%
Residual Solvents
N-Butanol ≤ 0.30%
Ethanol ≤ 0.30%
Test Standard Enterprise Standard
Kev siv Intermediate ntawm Pirfenidone (CAS: 53179-13-8)

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo

Qhov zoo:

1

FAQ:

Daim ntawv thov:

2-Hydroxy-5-Methylpyridine (CAS: 1003-68-5) yog siv los ua tshuaj nruab nrab ntawm Pirfenidone (CAS: 53179-13-8).Pirfenidone (PFD) yog ib yam tshiab ntawm pyridine ketones uas muaj broad-spectrum anti-fibrotic nyhuv, muaj peev xwm tiv thaiv thiab thim rov qab tsim ntawm fibrosis thiab caws pliav.Nws nkag mus rau hauv kev ua lag luam hauv Shionogi, Nyiv xyoo 2008 thiab tau pom zoo los ntawm US Food and Drug Administration.Nws yog thawj cov tshuaj uas tau dhau los ntawm theem III kev sim tshuaj (nrog rau kev rov ua dua, randomized, thiab cov tshuaj placebo-tswj) uas tau qhia nws cov txiaj ntsig hauv kev kho mob idiopathic pulmonary fibrosis (IPF);Ntxiv mus, cov tshuaj muaj cov txiaj ntsig zoo hauv kev kho qee cov kab mob fibrotic xws li lub raum interstitial fibrosis thiab daim siab fibrosis.

Sau koj cov lus ntawm no thiab xa tuaj rau peb